Tyme Technologies Inc TYME:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:17 PM EDT
1.25quote price arrow down-0.02 (-1.57%)
Volume
25,314
Close
1.27UNCH (UNCH)
Volume
2,696,142
52 week range
0.85 - 4.99

...

Loading . . .
  • Open1.25
  • Day High1.27
  • Day Low1.20
  • Prev Close1.27
  • 52 Week High4.99
  • 52 Week High Date02/03/21
  • 52 Week Low0.85
  • 52 Week Low Date11/02/20

Key Stats

  • Market Cap218.71M
  • Shares Out172.21M
  • 10 Day Average Volume3.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.03
  • YTD % Change4.1

KEY STATS

  • Open1.25
  • Day High1.27
  • Day Low1.20
  • Prev Close1.27
  • 52 Week High4.99
  • 52 Week High Date02/03/21
  • 52 Week Low0.85
  • 52 Week Low Date11/02/20
  • Market Cap218.71M
  • Shares Out172.21M
  • 10 Day Average Volume3.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.03
  • YTD % Change4.1

RATIOS/PROFITABILITY

  • EPS (TTM)-0.22
  • P/E (TTM)-5.83
  • Fwd P/E (NTM)-6.68
  • EBITDA (MRQ)-27.212M
  • ROE (MRQ)-47.97%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/07/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Tyme Technologies Inc

There is no recent news for this security.

Profile

MORE
TYME Technologies, Inc. is a biotechnology company. The Company is focused on developing cancer metabolism-based therapies (CMBTsTM) for solid tumors and hematologic cancers. The Company’s lead clinical CMBT compound, SM-88, is an oral investigational modified tyrosine derivative that is hypothesized to interrupt the metabolic processes of cancer cells by breaking down the cells’ key defenses and leading to cell death through oxidative stress and exposure to the body’s...
Steve Hoffman
Chairman
Richard Cunningham
Chief Executive Officer
Michele Korfin
Chief Operating Officer
Frank Porfido
Chief Financial Officer
Address
1 PLUCKEMIN WAY - SUITE 103
Bedminster, NJ
07921
United States

Top Peers

SYMBOLLASTCHG%CHG
OBSV
Obseva SA
2.94UNCHUNCH
NXTC
NextCure Inc
7.94+0.03+0.38%
SRRA
Sierra Oncology Inc
18.08-0.06-0.33%
UBX
UNITY Biotechnology Inc
4.15-0.10-2.35%
GRTX
Galera Therapeutics Inc
9.33-0.38-3.91%